ClinicalTrials.Veeva
Menu

Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Follicular Lymphoma
Recurrence
B-Cell Chronic Lymphocytic Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....

Enrolling
Relapsed Non-Hodgkin Lymphoma
Large B-cell Lymphoma
Drug: Rondecabtagene autoleucel (ronde-cel)
Drug: Fludarabine

Phase 1, Phase 2

Lyell Immunopharma

Indianapolis, Indiana, United States of America and 34 other locations

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Active, not recruiting
Non-Hodgkin's Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: ABBV-525

Phase 1

AbbVie
AbbVie

Indianapolis, Indiana, United States and 38 other locations

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

A Phase 1/2a study to assess the safety, tolerability, PK and biological activity of CCS1477 (inobrodib) in patients with Non-Hodgkin...

Enrolling
Non Hodgkin Lymphoma
Peripheral T Cell Lymphoma
Drug: Elranatamab
Drug: Venetoclax

Phase 1, Phase 2

CellCentric

Indianapolis, Indiana, United States and 38 other locations

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Active, not recruiting
Classic Follicular Lymphoma
Diffuse Large B-Cell Lymphoma
Drug: Epcoritamab

Phase 2

Genmab
Genmab

Indianapolis, Indiana, United States and 71 other locations

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma (OLYMPIA-1)

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling
Follicular Lymphoma (FL)
Drug: Cyclophosphamide
Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 193 other locations

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

The study is focused on patients with Diffuse Large B-cell Lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Enrolling
Diffuse Large B-cell Lymphoma (DLBCL)
Drug: Cyclophosphamide
Drug: Odronextamab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 196 other locations

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...

Active, not recruiting
Follicular Lymphoma (FL)
Drug: Odronextamab
Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 147 other locations

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma (OLYMPIA-5)

Non-Hodgkin 's Lymphoma (NHL).This study will be made up of two parts (Part 1 not randomized, Part 2 randomized - control...

Enrolling
Relapsed/Refractory Follicular Lymphoma
Relapsed/Refractory Marginal Zone Lymphoma (R/R MZL)
Drug: Lenalidomide
Drug: Odronextamab

Phase 3

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 171 other locations

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1)

Follicular Lymphoma (FL) is the second most common B-cell cancer and the most common type of cancer of lymphocytes. Unfortunately, this dise...

Active, not recruiting
Follicular Lymphoma (FL)
Drug: Lenalidomide
Drug: Rituximab

Phase 3

Genmab
Genmab

Indianapolis, Indiana, United States and 282 other locations

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have previously received treatm...

Active, not recruiting
Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia
Drug: Pirtobrutinib
Drug: Bendamustine

Phase 3

Loxo Oncology
Loxo Oncology

Indianapolis, Indiana, United States and 233 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2026 Veeva Systems